SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001469709-15-000627
Filing Date
2015-11-23
Accepted
2015-11-23 16:37:32
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 ENDV 10-Q 09/30/15 endv10q_093015apg.htm 10-Q 515460
2 GRAPHIC endv10q_093015apg001.jpg GRAPHIC 38214
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 10774
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3962
  Complete submission text file 0001469709-15-000627.txt   2247871

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE endv-20150930.xml EX-101.INS 313175
6 XBRL CALCULATION FILE endv-20150930_cal.xml EX-101.CAL 38682
7 XBRL DEFINITION FILE endv-20150930_def.xml EX-101.DEF 47118
8 XBRL LABEL FILE endv-20150930_lab.xml EX-101.LAB 178159
9 XBRL PRESENTATION FILE endv-20150930_pre.xml EX-101.PRE 143260
10 XBRL SCHEMA FILE endv-20150930.xsd EX-101.SCH 30441
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 151250084
SIC: 2834 Pharmaceutical Preparations